July 8, 2016
The chairman of otolaryngology at Weill Cornell Medicine, spoke to the Huffington Post about the condition that put comedian Sarah Silverman in the ICU last week.
July 5, 2016
WCM researchers, physicians and a standing-room only crowd of about 100 people discussed the goals of the government's "Cancer Moonshot" mission, which aims to accelerate cancer research, foster data sharing and collaboration and improve patient access to care within five years.
July 5, 2016
Women treated at a hospital after cardiac arrest are less likely than men to receive potentially life-saving procedures, according to new research published in the Journal of the American Heart Association.
July 1, 2016
A new gene therapy developed by scientists at Weill Cornell Medicine could eventually prevent the life-threatening effects of peanut allergy with just a single dose, according to a new pre-clinical study.
July 1, 2016
The Performing Arts Medicine Association (PAMA) will hold its 2016 Annual Meeting in New York for the first time ever, with our own Center for the Performing Artist hosting the 6-day event on our campus in July.
June 23, 2016
NewYork-Presbyterian/Weill Cornell Medical Center is now one of about 100 Joint Commission Comprehensive Stroke Centers in the country, providing advanced stroke care and exceptional, around-the-clock treatment.
June 17, 2016
The trial will evaluate the safety and efficacy of a stenting procedure to relieve the symptoms of pulsatile tinnitus in patients with significant venous sinus stenosis.
June 15, 2016
The first large, systemic study of “resident-to-resident elder mistreatment" found that about one in five nursing home residents experience verbal or physical abuse from their roommates or other residents.
June 8, 2016
Drug monitoring programs could be useful in the fight against the growing epidemic of opioid abuse, according to new study by lead by Weill Cornell Medicine researcher.
June 6, 2016
Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.
